TOI insider buying – Oncology Institute, Inc.
23 insider purchases since 2016 worth $4.5M by 8 different insiders. Last 12 months: 12 purchases, $2.6M. Most recent filing: 2026-07-22.
Same time range as the chart above - each mark sits under the week of the trade. Circles = purchases (height = price paid, size = amount), red triangles = open-market sales of $50k+. Prices as reported, not adjusted for later stock splits.
Purchases are open-market buys (SEC Form 4, code "P") - insiders paying with their own money. Sales are open-market sales (code "S") of $50,000 or more; many sales are pre-planned (Rule 10b5-1) or made for taxes and diversification. Each row links to the original filing.
Bought, sold, still holding?
| Insider | Bought | First / last buy | Sold since 2016 | Holds now* | Status |
|---|---|---|---|---|---|
| Chernett Jorey 10% Owner | $2.6M 12× · 777,914 sh | 2026-03-13 2026-07-21 | – | 10,660,858 shares as of 2026-08-17 | Holds - never sold |
| BARASCH RICHARD A Director | $1.5M 5× · 1,419,448 sh | 2021-11-16 2025-03-26 | – | 2,635,881 shares as of 2025-07-28 | Holds - never sold |
| Shah Mihir CFO | $126,989 1× · 100,000 sh | 2023-12-14 2023-12-14 | – | 474,931 shares as of 2024-05-23 | Holds - never sold |
| Pacala Mark L Director | $94,184 1× · 90,562 sh | 2025-03-26 2025-03-26 | 1× · $200,000 last 2025-11-18 | 286,881 shares as of 2026-07-29 | Sold part |
| Miller Matthew P Officer | $70,000 1× · 73,684 sh | 2022-12-16 2022-12-16 | – | 242,992 shares as of 2023-03-21 | Holds - never sold |
| Hively Brad Director | $50,000 1× · 300,000 sh | 2024-11-26 2024-11-26 | 5× · $6.0M last 2025-12-15 | 411,976 shares as of 2026-08-24 | Sold part |
| Johnson Karen Marie Director | $37,673 1× · 36,224 sh | 2025-03-26 2025-03-26 | – | 319,410 shares as of 2026-07-29 | Holds - never sold |
| Virnich Daniel CEO | $23,546 1× · 22,640 sh | 2025-03-26 2025-03-26 | – | 2,337,166 shares as of 2026-05-22 | Holds - never sold |
* Shares held after the insider's most recent SEC filing for this company (all share classes, direct and indirect). If an insider stops filing, later changes are not known.
Insider buying and selling by year
| Year | Purchases | Bought | Buyers | Sales | Sold |
|---|---|---|---|---|---|
| 2026 | 12 | $2.6M | 1 | 3 | $611,540 |
| 2025 | 4 | $1.6M | 4 | 7 | $34.4M |
| 2024 | 1 | $50,000 | 1 | 2 | $155,386 |
| 2023 | 2 | $154,489 | 2 | 2 | $174,440 |
| 2022 | 1 | $70,000 | 1 | 22 | $19.9M |
| 2021 | 3 | $76,438 | 1 | – | – |
Insider purchases
| Filed | Insider | Role | Shares | Avg price | Value | Holdings | Filing |
|---|---|---|---|---|---|---|---|
| 2026-07-22 | Chernett Jorey | 10% Owner | 18,000 | $5.27 | $94,860 | +0.2% | SEC |
| 2026-07-13 | Chernett Jorey | 10% Owner | 15,000 | $5.85 | $87,750 | +0.1% | SEC |
| 2026-06-24 | Chernett Jorey | 10% Owner | 18,000 | $5.02 | $90,360 | +0.2% | SEC |
| 2026-06-05 | Chernett Jorey | 10% Owner | 12,000 | $4.75 | $57,000 | +0.1% | SEC |
| 2026-05-21 | Chernett Jorey | 10% Owner | 38,500 | $4.07 | $156,595 | +0.4% | SEC |
| 2026-05-20 | Chernett Jorey | 10% Owner | 30,000 | $4.09 | $122,700 | +0.3% | SEC |
| 2026-04-13 | Chernett Jorey | 10% Owner | 20,000 | $3.10 | $62,000 | +0.2% | SEC |
| 2026-03-30 | Chernett Jorey | 10% Owner | 27,429 | $2.96 | $81,190 | +0.3% | SEC |
| 2026-03-27 | Chernett Jorey | 10% Owner | 50,000 | $3.15 | $157,500 | +0.5% | SEC |
| 2026-03-25 | Chernett Jorey | 10% Owner | 125,000 | $3.11 | $388,750 | +1.2% | SEC |
| 2026-03-23 | Chernett Jorey | 10% Owner | 25,000 | $3.35 | $83,750 | +0.2% | SEC |
| 2026-03-17 | Chernett Jorey | 10% Owner | 398,985 | $3.07 | $1.2M | +4.0% | SEC |
| 2025-03-28 | Virnich Daniel | CEO | 22,640 | $1.04 | $23,546 | +3.2% | SEC |
| 2025-03-28 | Pacala Mark L | Director | 90,562 | $1.04 | $94,184 | +67.4% | SEC |
| 2025-03-28 | Johnson Karen Marie | Director | 36,224 | $1.04 | $37,673 | +21.7% | SEC |
| 2025-03-28 | BARASCH RICHARD A | Director | 1,358,448 | $1.04 | $1.4M | +325.6% | SEC |
| 2024-12-02 | Hively Brad | Director | 300,000 | $0.17 | $50,000 | +81.8% | SEC |
| 2023-12-18 | Shah Mihir | CFO | 100,000 | $1.27 | $126,989 | +43.8% | SEC |
| 2023-03-21 | BARASCH RICHARD A | Director | 50,000 | $0.55 | $27,500 | +24.1% | SEC |
| 2022-12-20 | Miller Matthew P | Officer | 73,684 | $0.95 | $70,000 | +72.5% | SEC |
| 2021-11-24 | BARASCH RICHARD A | Director | 5,000 | $6.92 | $34,608 | +5.5% | SEC |
| 2021-11-24 | BARASCH RICHARD A | Director | 5,000 | $6.34 | $31,710 | +5.8% | SEC |
| 2021-11-18 | BARASCH RICHARD A | Director | 1,000 | $10.12 | $10,120 | +1.2% | SEC |
Insider sales
| Filed | Insider | Role | Shares | Avg price | Value | Type | Filing |
|---|---|---|---|---|---|---|---|
| 2026-07-16 | Podnos Yale | Officer | 23,452 | $6.41 | $150,358 | Pre-planned (10b5-1) | SEC |
| 2026-06-09 | Podnos Yale | Officer | 23,451 | $5.38 | $126,166 | Pre-planned (10b5-1) | SEC |
| 2026-04-16 | Kaushal Mohit | Director | 95,719 | $3.50 | $335,016 | Pre-planned (10b5-1) | SEC |
| 2025-12-16 | Hively Brad | Director | 13,333 | $3.77 | $50,265 | Sale | SEC |
| 2025-11-20 | Pacala Mark L | Director | 50,000 | $4.00 | $200,000 | Sale | SEC |
| 2025-09-05 | M33 Growth I GP LLC | Director | 6,700,000 | $3.09 | $20.7M | Sale | SEC |
| 2025-08-21 | Hively Brad | Director | 20,221 | $4.06 | $82,097 | Sale | SEC |
| 2025-06-09 | M33 Growth I GP LLC | Director | 750,000 | $3.05 | $2.3M | Sale | SEC |
| 2025-06-05 | Hively Brad | Director | 1,976,137 | $2.87 | $5.7M | Sale | SEC |
| 2025-05-22 | M33 Growth I GP LLC | Director | 2,000,000 | $2.71 | $5.4M | Sale | SEC |
| 2024-01-26 | Havencrest Healthcare Partners, L.P. | 10% Owner | 43,776 | $2.21 | $96,835 | Sale | SEC |
| 2024-01-23 | TOI HC I, LLC | 10% Owner | 27,587 | $2.12 | $58,551 | Sale | SEC |
| 2023-11-21 | Hively Brad | Director | 25,000 | $2.24 | $56,000 | Sale | SEC |
| 2023-11-15 | Hively Brad | Director | 47,000 | $2.52 | $118,440 | Sale | SEC |
| 2022-11-15 | Havencrest Healthcare Partners, L.P. | 10% Owner | 365,321 | $2.33 | $851,198 | Sale | SEC |
Showing the latest 15 of 36 sales of $50,000+ since 2016.
Compiled automatically from public SEC filings. Not investment advice. Get every new insider purchase in the daily report.
Get every new insider purchase the day it's filed
Daily report with all SEC insider buys, cluster buys, company events and the crypto money-flow radar.
Get started free